P1 reagents are now available for NextSeq 1000 and NextSeq 2000 Systems, offering added flexibility to meet your project's needs
Order NowEnable comprehensive genomic profiling with accurate and comprehensive homologous recombination deficiency assessment
Learn MoreIllumina offers webinars and free online training courses to get the most out of your experiments and products
View Webinars View CoursesFilter by microbiology, cancer research, and more. Compare and cart products.
Find the Right KitBasepaws uses DNA sequencing and DRAGEN to give cat owners information about their pet’s breed, traits, and health risks
Read ArticleDate | Publication | Title |
---|---|---|
13 Jul 2022 | Business Weekly | Ovarian cancer pioneer builds on Illumina Accelerator success |
28 Jun 2022 | Business Weekly | Cambridge payback as Illumina invests in £30m genomics venture fund |
28 Jun 2022 | Genome Web | Illumina Invests in UK-Based Genomics Venture Fund Tied to Startup Accelerator Program |